A detailed history of Lazard Asset Management LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 865 shares of SGMO stock, worth $1,764. This represents 0.0% of its overall portfolio holdings.

Number of Shares
865
Previous 23,437 96.31%
Holding current value
$1,764
Previous $15,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.36 - $0.65 $8,125 - $14,671
-22,572 Reduced 96.31%
865 $0
Q1 2024

May 14, 2024

SELL
$0.42 - $1.38 $5,734 - $18,841
-13,653 Reduced 36.81%
23,437 $15,000
Q4 2023

Feb 14, 2024

BUY
$0.3 - $0.63 $611 - $1,284
2,039 Added 5.82%
37,090 $20,000
Q3 2023

Nov 14, 2023

SELL
$0.58 - $1.47 $26,115 - $66,189
-45,027 Reduced 56.23%
35,051 $21,000
Q2 2023

Aug 14, 2023

BUY
$1.11 - $1.74 $74,912 - $117,430
67,489 Added 536.1%
80,078 $104,000
Q1 2023

May 15, 2023

SELL
$1.66 - $3.67 $19,290 - $42,649
-11,621 Reduced 48.0%
12,589 $21,000
Q4 2022

Feb 14, 2023

SELL
$2.77 - $5.07 $7,628 - $13,962
-2,754 Reduced 10.21%
24,210 $76,000
Q3 2022

Nov 14, 2022

BUY
$4.27 - $6.39 $192 - $287
45 Added 0.17%
26,964 $131,000
Q2 2022

Aug 09, 2022

BUY
$3.28 - $6.21 $48,383 - $91,603
14,751 Added 121.23%
26,919 $111,000
Q1 2022

May 13, 2022

BUY
$5.23 - $7.82 $17,478 - $26,134
3,342 Added 37.87%
12,168 $70,000
Q4 2021

Feb 09, 2022

BUY
$7.29 - $10.97 $11,372 - $17,113
1,560 Added 21.47%
8,826 $65,000
Q3 2021

Nov 15, 2021

SELL
$9.01 - $12.01 $80,999 - $107,969
-8,990 Reduced 55.3%
7,266 $65,000
Q2 2021

Aug 12, 2021

BUY
$10.17 - $12.64 $163,025 - $202,619
16,030 Added 7092.92%
16,256 $193,000
Q1 2021

May 14, 2021

SELL
$10.88 - $17.05 $55,716 - $87,313
-5,121 Reduced 95.77%
226 $2,000
Q4 2020

Feb 11, 2021

BUY
$9.23 - $18.18 $49,352 - $97,208
5,347 New
5,347 $83,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $319M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.